AAAAAA

   
Results: 1-21 |
Results: 21
PHARMACOKINETICS OF THE 5HT(3) RECEPTOR ANTAGONIST TROPISETRON IN CHILDREN
Authors: GAEDICKE G ERTTMANN R HENZE G HARTMANN W DRECHSLER S GRASS P FAERBER L KUTZ K
Citation: G. Gaedicke et al., PHARMACOKINETICS OF THE 5HT(3) RECEPTOR ANTAGONIST TROPISETRON IN CHILDREN, Pediatric hematology and oncology, 13(5), 1996, pp. 405-416
PHARMACOKINETICS OF ORALLY-ADMINISTERED CYCLOSPORINE IN PATIENTS WITHCROHNS-DISEASE
Authors: FLUCKIGER SS SCHMIDT C MEYER A KALLAY Z JOHNSTON A KUTZ K
Citation: Ss. Fluckiger et al., PHARMACOKINETICS OF ORALLY-ADMINISTERED CYCLOSPORINE IN PATIENTS WITHCROHNS-DISEASE, Journal of clinical pharmacology, 35(7), 1995, pp. 681-687
ASSESSMENT OF GLOMERULAR-FILTRATION RATE AFTER MULTIPLE ADMINISTRATION OF A NEW ORAL FORMULATION OF CYCLOSPORINE IN CLINICALLY STABLE RENAL-TRANSPLANT PATIENTS
Authors: MUELLER EA KALLAY Z KOVARIK JM ARNS W RENNER E KUTZ K
Citation: Ea. Mueller et al., ASSESSMENT OF GLOMERULAR-FILTRATION RATE AFTER MULTIPLE ADMINISTRATION OF A NEW ORAL FORMULATION OF CYCLOSPORINE IN CLINICALLY STABLE RENAL-TRANSPLANT PATIENTS, Transplantation proceedings, 27(1), 1995, pp. 834-836
SANDIMMUN NEORAL PHARMACOKINETICS - IMPACT OF THE NEW ORAL FORMULATION
Authors: HOLT DW MUELLER EA KOVARIK JM VANBREE JB RICHARD F KUTZ K
Citation: Dw. Holt et al., SANDIMMUN NEORAL PHARMACOKINETICS - IMPACT OF THE NEW ORAL FORMULATION, Transplantation proceedings, 27(1), 1995, pp. 1434-1437
LACK OF INTERACTION BETWEEN FLUVASTATIN AND ORAL HYPOGLYCEMIC AGENTS IN HEALTHY-SUBJECTS AND IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: APPEL S RUFENACHT T KALAFSKY G TETZLOFF W KALLAY Z HITZENBERGER G KUTZ K
Citation: S. Appel et al., LACK OF INTERACTION BETWEEN FLUVASTATIN AND ORAL HYPOGLYCEMIC AGENTS IN HEALTHY-SUBJECTS AND IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, The American journal of cardiology, 76(2), 1995, pp. 29-32
IMPROVED DOSE LINEARITY OF CYCLOSPORINE PHARMACOKINETICS FROM A MICROEMULSION FORMULATION
Authors: MUELLER EA KOVARIK JM VANBREE JB TETZLOFF W GREVEL J KUTZ K
Citation: Ea. Mueller et al., IMPROVED DOSE LINEARITY OF CYCLOSPORINE PHARMACOKINETICS FROM A MICROEMULSION FORMULATION, Pharmaceutical research, 11(2), 1994, pp. 301-304
INFLUENCE OF A FAT-RICH MEAL ON THE PHARMACOKINETICS OF A NEW ORAL FORMULATION OF CYCLOSPORINE IN A CROSSOVER COMPARISON WITH THE MARKET FORMULATIONS
Authors: MUELLER EA KOVARIK JM VANBREE JB GREVEL J LUCKER PW KUTZ K
Citation: Ea. Mueller et al., INFLUENCE OF A FAT-RICH MEAL ON THE PHARMACOKINETICS OF A NEW ORAL FORMULATION OF CYCLOSPORINE IN A CROSSOVER COMPARISON WITH THE MARKET FORMULATIONS, Pharmaceutical research, 11(1), 1994, pp. 151-155
TREATMENT WITH OCTREOTIDE AND BROMOCRIPTINE IN PATIENTS WITH ACROMEGALY - AN OPEN PHARMACODYNAMIC INTERACTION STUDY
Authors: FREDSTORP L KUTZ K WERNER S
Citation: L. Fredstorp et al., TREATMENT WITH OCTREOTIDE AND BROMOCRIPTINE IN PATIENTS WITH ACROMEGALY - AN OPEN PHARMACODYNAMIC INTERACTION STUDY, Clinical endocrinology, 41(1), 1994, pp. 103-108
CYCLOSPORINE DISPOSITION AND METABOLITE PROFILES IN RENAL-TRANSPLANT PATIENTS RECEIVING A MICROEMULSION FORMULATION
Authors: KOVARIK JM VERNILLET L MUELLER EA FREIBURGHAUS R NIEDERBERGER W KUTZ K
Citation: Jm. Kovarik et al., CYCLOSPORINE DISPOSITION AND METABOLITE PROFILES IN RENAL-TRANSPLANT PATIENTS RECEIVING A MICROEMULSION FORMULATION, Therapeutic drug monitoring, 16(5), 1994, pp. 519-525
WITHIN-DAY CONSISTENCY IN CYCLOSPORINE PHARMACOKINETICS FROM A MICROEMULSION FORMULATION IN RENAL-TRANSPLANT PATIENTS
Authors: KOVARIK JM MUELLER EA VANBREE JB ARNS W RENNER E KUTZ K
Citation: Jm. Kovarik et al., WITHIN-DAY CONSISTENCY IN CYCLOSPORINE PHARMACOKINETICS FROM A MICROEMULSION FORMULATION IN RENAL-TRANSPLANT PATIENTS, Therapeutic drug monitoring, 16(3), 1994, pp. 232-237
ELIMINATION KINETICS OF TERBINAFINE FROM HUMAN PLASMA AND TISSUES FOLLOWING MULTIPLE-DOSE ADMINISTRATION, AND COMPARISON WITH 3 MAIN METABOLITES
Authors: ZEHENDER H CABIAC MD DENOUEL J FAERGEMANN J DONATSCH P KUTZ K HUMBERT H
Citation: H. Zehender et al., ELIMINATION KINETICS OF TERBINAFINE FROM HUMAN PLASMA AND TISSUES FOLLOWING MULTIPLE-DOSE ADMINISTRATION, AND COMPARISON WITH 3 MAIN METABOLITES, Drug investigation, 8(4), 1994, pp. 203-210
THE PHARMACOKINETICS OF SANDIMMUN-NEORAL - A NEW ORAL FORMULATION OF CYCLOSPORINE
Authors: HOLT DW MUELLER EA KOVARIK JM VANBREE JB KUTZ K
Citation: Dw. Holt et al., THE PHARMACOKINETICS OF SANDIMMUN-NEORAL - A NEW ORAL FORMULATION OF CYCLOSPORINE, Transplantation proceedings, 26(5), 1994, pp. 2935-2939
MINOR INFLUENCE OF A FAT-RICH MEAL ON THE PHARMACOKINETICS OF A NEW ORAL FORMULATION OF CYCLOSPORINE
Authors: MUELLER EA KOVARIK JM KUTZ K
Citation: Ea. Mueller et al., MINOR INFLUENCE OF A FAT-RICH MEAL ON THE PHARMACOKINETICS OF A NEW ORAL FORMULATION OF CYCLOSPORINE, Transplantation proceedings, 26(5), 1994, pp. 2957-2958
CYCLOSPORINE PHARMACOKINETICS AND VARIABILITY FROM A MICROEMULSION FORMULATION - A MULTICENTER INVESTIGATION IN KIDNEY-TRANSPLANT PATIENTS
Authors: KOVARIK JM MUELLER EA VANBREE JB FLUCKIGER SS LANGE H SCHMIDT B BOESKEN WH LISON AE KUTZ K
Citation: Jm. Kovarik et al., CYCLOSPORINE PHARMACOKINETICS AND VARIABILITY FROM A MICROEMULSION FORMULATION - A MULTICENTER INVESTIGATION IN KIDNEY-TRANSPLANT PATIENTS, Transplantation, 58(6), 1994, pp. 658-663
PHARMACOKINETICS AND TOLERABILITY OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN RENAL-ALLOGRAFT RECIPIENTS - A CONCENTRATION-CONTROLLEDCOMPARISON WITH THE COMMERCIAL FORMULATION
Authors: MUELLER EA KOVARIK JM VANBREE JB LISON AE KUTZ K
Citation: Ea. Mueller et al., PHARMACOKINETICS AND TOLERABILITY OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN RENAL-ALLOGRAFT RECIPIENTS - A CONCENTRATION-CONTROLLEDCOMPARISON WITH THE COMMERCIAL FORMULATION, Transplantation, 57(8), 1994, pp. 1178-1182
REDUCED INTERINDIVIDUAL AND INTRAINDIVIDUAL VARIABILITY IN CYCLOSPORINE PHARMACOKINETICS FROM A MICROEMULSION FORMULATION
Authors: KOVARIK JM MUELLER EA VANBREE JB TETZLOFF W KUTZ K
Citation: Jm. Kovarik et al., REDUCED INTERINDIVIDUAL AND INTRAINDIVIDUAL VARIABILITY IN CYCLOSPORINE PHARMACOKINETICS FROM A MICROEMULSION FORMULATION, Journal of pharmaceutical sciences, 83(3), 1994, pp. 444-446
A COMPARISON OF OCTREOTIDE, BROMOCRIPTINE, OR A COMBINATION OF BOTH DRUGS IN ACROMEGALY
Authors: FLOGSTAD AK HALSE J GRASS P ABISCH E DJOSELAND O KUTZ K BODD E JERVELL J
Citation: Ak. Flogstad et al., A COMPARISON OF OCTREOTIDE, BROMOCRIPTINE, OR A COMBINATION OF BOTH DRUGS IN ACROMEGALY, The Journal of clinical endocrinology and metabolism, 79(2), 1994, pp. 461-465
PHARMACOLOGY, TOXICOLOGY AND HUMAN PHARMACOKINETICS OF TROPISETRON
Authors: KUTZ K
Citation: K. Kutz, PHARMACOLOGY, TOXICOLOGY AND HUMAN PHARMACOKINETICS OF TROPISETRON, Annals of oncology, 4, 1993, pp. 190000015-190000018
BIOEQUIVALENCE OF SOFT GELATIN CAPSULES AND ORAL SOLUTION OF A NEW CYCLOSPORINE FORMULATION
Authors: KOVARIK JM MUELLER EA JOHNSTON A HITZENBERGER G KUTZ K
Citation: Jm. Kovarik et al., BIOEQUIVALENCE OF SOFT GELATIN CAPSULES AND ORAL SOLUTION OF A NEW CYCLOSPORINE FORMULATION, Pharmacotherapy, 13(6), 1993, pp. 613-617
PHARMACOKINETICS AND HEMODYNAMIC-EFFECTS OF A SINGLE ORAL DOSE OF THENOVEL ACE-INHIBITOR SPIRAPRIL IN PATIENTS WITH CHRONIC LIVER-DISEASE
Authors: KRAHENBUHL S GRASS P SURVE A KUTZ K REICHEN J
Citation: S. Krahenbuhl et al., PHARMACOKINETICS AND HEMODYNAMIC-EFFECTS OF A SINGLE ORAL DOSE OF THENOVEL ACE-INHIBITOR SPIRAPRIL IN PATIENTS WITH CHRONIC LIVER-DISEASE, European Journal of Clinical Pharmacology, 45(3), 1993, pp. 247-253
EFFECTS OF DICLOFENAC ON ISRADIPINE PHARMACOKINETICS AND PLATELET-AGGREGATION IN VOLUNTEERS
Authors: SOMMERS DK KOVARIK JM MEYER EC VANWYK M SNYMAN JR BLOM M OTT S GRASS P KUTZ K
Citation: Dk. Sommers et al., EFFECTS OF DICLOFENAC ON ISRADIPINE PHARMACOKINETICS AND PLATELET-AGGREGATION IN VOLUNTEERS, European Journal of Clinical Pharmacology, 44(4), 1993, pp. 391-393
Risultati: 1-21 |